shG9a tumour cells transfected with a RAC1Q61L (a constitutively active RAC1) expressing vector restored the oncogenic phenotype, suggesting that RAC1 is a key downstream effector of G9a [144]. This evidence concerns the gene RAC1 and neoplasm.